Trials / Not Yet Recruiting
Not Yet RecruitingNCT06620939
The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence
The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence After Hysteroscopic Polypectomy: Protocol of a Multi-center Randomised Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 558 (estimated)
- Sponsor
- Zhang Jian · Academic / Other
- Sex
- Female
- Age
- 20 Years – 48 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to determine whether the LNG-IUS is more effective to that of expectant in preventing endometrial polyp recurrence after hysteroscopic polypectomy. Researchers will compare LNG-IUS to expectant management to see if LNG-IUS works to reduce the recurrence rate of endometrial polyps. Participants will: Receive Mirena placement or not after hysteroscopic polypectomy； Be scheduled for a follow-up with TVCD to screen for endometrial polyps recurrence every 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levonorgestrel Intrauterine System (LNG-IUS) | Participants in the intervention group will receive Mirena placement after hysteroscopic polypectomy |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2024-10-01
- Last updated
- 2024-10-04
Source: ClinicalTrials.gov record NCT06620939. Inclusion in this directory is not an endorsement.